BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 31953548)

  • 1. [Pathology of liver tumors].
    Schirmacher P
    Internist (Berl); 2020 Feb; 61(2):131-139. PubMed ID: 31953548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphomolecular Classification Update on Hepatocellular Adenoma, Hepatocellular Carcinoma, and Intrahepatic Cholangiocarcinoma.
    Katabathina VS; Khanna L; Surabhi VR; Minervini M; Shanbhogue K; Dasyam AK; Prasad SR
    Radiographics; 2022; 42(5):1338-1357. PubMed ID: 35776676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined hepatocellular cholangiocarcinoma: Controversies to be addressed.
    Wang AQ; Zheng YC; Du J; Zhu CP; Huang HC; Wang SS; Wu LC; Wan XS; Zhang HH; Miao RY; Sang XT; Zhao HT
    World J Gastroenterol; 2016 May; 22(18):4459-65. PubMed ID: 27182157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biliary tumors of the liver.
    Colombari R; Tsui WM
    Semin Liver Dis; 1995 Nov; 15(4):402-13. PubMed ID: 8578323
    [No Abstract]   [Full Text] [Related]  

  • 5. Mixed hepatocellular-cholangiocarcinoma may derive from "hepatogones".
    Hunt JP; Varnholt H
    Hepatobiliary Pancreat Dis Int; 2008 Feb; 7(1):105; author reply 105-6. PubMed ID: 18234649
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinicopathologic analysis of combined hepatocellular-cholangiocarcinoma according to the latest WHO classification.
    Akiba J; Nakashima O; Hattori S; Tanikawa K; Takenaka M; Nakayama M; Kondo R; Nomura Y; Koura K; Ueda K; Sanada S; Naito Y; Yamaguchi R; Yano H
    Am J Surg Pathol; 2013 Apr; 37(4):496-505. PubMed ID: 23388123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tumor grading of the hepatobiliary system].
    Jütte H; Tannapfel A
    Pathologe; 2016 Jul; 37(4):299-303. PubMed ID: 27342594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathology of combined hepatocellular-cholangiocarcinoma.
    Yeh MM
    J Gastroenterol Hepatol; 2010 Sep; 25(9):1485-92. PubMed ID: 20796144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraperitoneal rupture of cholangiocarcinoma in a patient with liver cirrhosis, type C, with hepatocellular carcinoma.
    Watanabe M; Akagi S; Hamamoto S
    Am J Gastroenterol; 1999 Aug; 94(8):2320-1. PubMed ID: 10445582
    [No Abstract]   [Full Text] [Related]  

  • 10. [Combined hepatocellular and cholangiocellular carcinoma: a case report with invasion to the left hepatic duct of hepatocellular carcinoma].
    Ogata T; Ohwada S; Fukusato T; Nakamura S; Kawashima Y; Morishita Y; Matsumoto M; Kon Y
    Nihon Shokakibyo Gakkai Zasshi; 1996 Jun; 93(6):428-32. PubMed ID: 8752762
    [No Abstract]   [Full Text] [Related]  

  • 11. Intraductal Hepatocellular Carcinoma without Parenchymal Tumor: A Case Report.
    Ramakrishna B; Shah GJ; Vyas F
    J Gastrointest Cancer; 2012 Sep; 43 Suppl 1():S77-9. PubMed ID: 21814761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary intrahepatic small-cell carcinoma arising from combined hepatocellular and cholangiocarcinomas.
    Khaw YL; Nolan N; Heaslip I; McCormick PA; Sheahan K
    J Clin Oncol; 2011 Jul; 29(21):e630-3. PubMed ID: 21606429
    [No Abstract]   [Full Text] [Related]  

  • 13. Intrahepatic cholangiocarcinoma: new insights in pathology.
    Sempoux C; Jibara G; Ward SC; Fan C; Qin L; Roayaie S; Fiel MI; Schwartz M; Thung SN
    Semin Liver Dis; 2011 Feb; 31(1):49-60. PubMed ID: 21344350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A histopathological study on combined hepatocellular and cholangiocarcinoma: cholangiocarcinoma component is originated from hepatocellular carcinoma.
    Wakasa T; Wakasa K; Shutou T; Hai S; Kubo S; Hirohashi K; Umeshita K; Monden M
    Hepatogastroenterology; 2007 Mar; 54(74):508-13. PubMed ID: 17523309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sarcomatoid combined hepatocellular-cholangiocarcinoma: a case report and review of literature.
    Chin S; Kim Z
    Int J Clin Exp Pathol; 2014; 7(11):8290-4. PubMed ID: 25550887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytologic features of fibrolamellar carcinoma with mucin production: a rare variant of combined hepatocellular-cholangiocarcinoma.
    Rosa M; Mohammadi A
    Diagn Cytopathol; 2014 May; 42(5):431-5. PubMed ID: 23008149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of mucinous cholangiocarcinoma showing features of hepatocellular carcinoma.
    Kai K; Ide Y; Miyoshi A; Masuda M; Ide T; Kitahara K; Irie H; Nakajima J; Noshiro H; Tokunaga O
    Pathol Int; 2013 Aug; 63(8):419-21. PubMed ID: 23957918
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-term prognosis of combined hepatocellular and cholangiocarcinoma after curative resection comparison with hepatocellular carcinoma and cholangiocarcinoma.
    Lee JH; Chung GE; Yu SJ; Hwang SY; Kim JS; Kim HY; Yoon JH; Lee HS; Yi NJ; Suh KS; Lee KU; Jang JJ; Kim YJ
    J Clin Gastroenterol; 2011 Jan; 45(1):69-75. PubMed ID: 20142755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of small combined hepatocellular and cholangiocellular carcinoma arising in a nodule of atypical adenomatous hyperplasia of the liver.
    Harada K; Terada T; Nakanuma Y; Furukawa Y; Kurumaya H
    Am J Gastroenterol; 1993 Nov; 88(11):1968-9. PubMed ID: 8237956
    [No Abstract]   [Full Text] [Related]  

  • 20. Hepatocellular cancer, cholangiocarcinoma, and metastatic tumors of the liver.
    Wagman LD
    Surg Oncol Clin N Am; 2015 Jan; 24(1):xiii-xiv. PubMed ID: 25444478
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.